Uncategorized

IACTA Pharmaceuticals and TALLC Corporation Announce Strategic Collaboration to Utilize Novel SmartCelle Topical Delivery Technology

by Business Wire • 2021/12/15 • 0 Comments

GUAYNABO, Puerto Rico & MONTREAL--(BUSINESS WIRE)--IACTA Pharmaceuticals and TALLC Corporation Announce Strategic Collaboration to Utilize Novel SmartCelle Topical Delivery Technology

← Study identifies characteristics that promote physicians’ trust in their organization

First patient enrolled in stand-alone Hydrus microstent trial →

Post navigation